Milk Thistle References
1. Wagner H, Horhammer L, Munster R. The chemistry of silymarin
(silybin), the active principle of the fruits of Silybum marianum (L.) Gaertn.
Arzneim-Forsch Drug Res 1968;18:688-96.
2. Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions
of flavonolignans from Silybum marianum fruits. Planta Medica 1984;50:248-50.
3. Silybum marianum (Milk Thistle). Alt Med Rev. 1999;4(4):272-274.
4. "Elements of Health, part one." Prescription
for Nutritional Healing, Phyllis Bach and James Balch, M.D., Avery 2000. (p
103)
5. Feher J, Deak G, Muzes G, Lang I, Neiderland V, Nekan K,
et al. Hepatoprotective activity of silymarin therapy in patients with chronic
alcoholic liver disease. Orv Hetil. 1990;130:51.
6. Schopen RD, et al. Therapy of Hepatoses. Therapeutic Use
of Silymarin. Med Welt. 1969;21:691-8.
7. Faulstich H, Jahn W, Wieland T. Silibin inhibition of amatoxin
uptake in the perfused rat liver. Arzneim-Forsch Drug Res 1980;30:452-4.
8. Tuchweber B, Sieck R, Trost W. Prevention by silibinin
of phalloidin induced hepatotoxicity. Toxicol Appl Pharmacol 1979;51:265-75.
9. Valenzuela A, et al. Silymarin Protection Against Hepatic
Lipid Peroxidation induced by Acute Ethanol Intoxification [in the Rat]. Biochem
Pharm. 1985;34:2209-12.
10. Ferenci P, Dragosics B, Dittrich H, Frank H., Benda L,
Lochs H, et al. Randomized controlled trial of silymarin treatment in patients
with cirrhosis of the liver. J Hepatol. 1989;9:105-113.
11. Feher J, Lang I, Deak G, et al. Free radicals in tissue
damage in liver diseases and therapeutic approach. Tokai J Exp Clin Med 1986;11:121-34.
12. Zi X, Feyes DK, Agarwai R. Anticarcinogenic effect of
a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468:
induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease
in kinase activity of cyclin-dependent kinases and associated cyclins. Clin
Cancer Res. 1998;4(4):1055-1064.
13. Vogel G, et al. Protection by Silibinin Against Amanita
Phalloides Intoxification in Beagles. Toxicol Appl Pharm. 1984;73:355-62.
14. Dehpour AR, et al. Liquorice Components Protect Liver
Damage Induced by Actaminophen. Poster Presentation, 48th Annual Meeting of
the International Congress of the Society of Medicinal Plant Research, P2A/23.
Sep2000.
15. Shear NH, Malkiewicz IM, Klein D, et al. Acetaminophen-induced
Toxicity to Human Epidermoid Cell Line A431 and Hepatoblastoma Cell Line Hep
G2, In Vitro, is Diminished by Silymarin. Skin Pharmacol. 1995;8(6):279-91.
16. White L, Mavor S. Kids, Herbs, Health. Loveland, Colo:
Interweave Press; 1998:22, 36.
17. Reyes H. The spectrum of liver and gastrointestinal disease
seen in cholestasis of pregnancy. Gastroert Clin N Am 1992;21:905-21.
Turmeric References
1. Balch JF, and Balch PA. Prescription for Nutritional Healing,
3rd ed. New York: Penguin Putnam Avery, 2000: 754-762.
2. Turmeric, Dietary Supplement Information Bureau:
http://content.nhiondemand.com/dse/consumer/monoAll-style.asp?objID=100094&ctype=ds&mtyp=1
3. Curcuminoids, PDR Health:
http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/cur_0087.shtml
4. Turmeric, PDR Health:
http://www.pdrhealth.com/drug_info/nmdrugprofiles/herbaldrugs/102800.shtml
5. Kang BY, Song YJ, Kim KM, et al. Curcumin inhibits Th1
cytokine profile in CD4+ T cells by suppressing interleukin-12 production in
macrophages. BR J Pharmacol. 1999:128:380-384.
6. Chan MM-Y. Inhibition of tumor necrosis factor by curcumin,
a phytochemical. Biochem Pharmacol. 1995; 49:1551-1556.
7. Khopde SM, Priyadarsini KI, Guha SN, et al. Inhibition
of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms
by pulse radiolysis. Biosci Biotechnol Biochem. 2000; 64:503-509.
8. Reddy AC, et al. Effect of Dietary Turmeric (Curcuma longa)
on Iron-induced Lipid Peroxidation in the Rat Liver. Food Chem Toxicol. Mar1994;32(3):279-83.
***
9. Barthelmy S, Vergnes L, Moynier M, et al. Curcumin and
curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency
virus long terminal repeat. Res Virol. 1998; 149:43-52.
10. Ammon HP, et al. Mechanism of Anti-inflammatory Actions
of Curcumin and Boswellic Acids. J Ethnopharmacol. 1993;38:113. ***
11. Srivastava V, et al. Effect of Curcumin on Platelet Aggregation
and Vascular Prostacyclin Synthesis. Arzneim Forsch/Drug Res. 1986;36:715-17.
12. Ammon HP, et al. Pharmacology of Curcuma longa. Planta
Med. Feb1991;57(1):1-7.
13. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan
B. Treatment of osteoarthritis with a herbomineral formulation: a double-blind,
placebo-controlled, cross-over study. J Ethnopharmacol. May1991;33(1-2):91-5.
14. Mehta K, et al. Antiproliferative Effect of Curcumin (Diferuloylmethane)
against Human Breast Tumor Cell Line. Anticancer Drugs. Jun1997;8(5):470-81.
15. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S,
Miyazaki M, et al. Curcumin inhibits interleukin 8 production and enhances interleukin
8 receptor expression on the cell surface:impact on human pancreatic carcinoma
cell growth by autocrine regulation. Cancer. Sep2002;95(6):1206-14.
16. Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an
in vivo inhibitor of angiogenesis. Mol Med. 1998; 4:376-383.
17. Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit
the angiogenic response stimulated by fibroblast growth factor-2, including
expression of matrix metalloproteinase gelatinase B. J Biol Chem. 2000; 275:10405-10412.
18. Huang MT, Newmark HL, Fenkel K. Inhibitory effects of
curcumin on tumorigenesis in mice. J Cell Biochem Suppl. 1997; 27:26-34.
19. Kuo ML, Huang TS, Lin JK. Curcumin, an antioxidant and
anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys
Acta. 1996; 1317:95-100.
20. Kawamori T, et al. Chemopreventive Effect of Curcumin,
A Naturally Occurring Anti-inflammatory Agent, During the Promotion/Progression
Stages of Colon Cancer. Cancer Res. Feb1999;59(3):597-601.
21. Venkatesan N, Punithavathi D, Arumugam V. Curcumin prevents
adriamycin nephrotoxicity in rats. Br J Pharmacol. 2000; 129:231-234.***
22. Venkatesan N. Pulmonary protective effects of curcumin
against paraquat toxicity. Life Sci. 2000; 66:PL21-PL28.
23. Park EJ, Jeon CH, Ko G, et al. Protective effect of curcumin
in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol. 2000;
52:437-440.***
24. Soni KB, et al. Effect of Oral Curcumin Administration
on Serum Peroxides and Cholesterol Levels in Human Volunteers. Indian J Physiol
Pharmacol. Oct1992;36(4):273-75. ***
25. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral
administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic
effects in rabbits with experimental atherosclerosis. Atherosclerosis. 1999;
147:371-378.
26. Mazumder A, Raghavan K, Weinstein J, et al. Inhibition
of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol.
1995; 49:1165-1170.
27. Pandya U, Saini MK, Jin GF, et al. Dietary curcumin prevents
ocular toxicity of naphthalene in rats. Toxicol Lett. 2000; 115:195-204.
28. Sidhu GS, Mani H, Gaddipati JP, et al. Curcumin enhances
wound healing in streptozotocin induced diabetic rats and genetically diabetic
mice. Wound Rep Reg. 1999; 7:362-374.